• Home
  • Clinical Trials
  • Osteoporosis
  • A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy

Category: Osteoporosis
Condition:   Back Pain
Interventions:   Drug: REGN475/SAR164877;   Drug: Placebo
Sponsors:   Sanofi-Aventis;   Regeneron Pharmaceuticals
Terminated - verified August 2011
Details